(1 - 8 von 9
)
Adesh Kaul | EuropaWire.eu
news.europawire.eu
BASEL, 05-Mar — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Adesh Kaul will join Basilea's Management Committee as Chief Corporate Development Officer effective March 01, He will continue to be responsible for strategic planning, business development & … Read the ...
Basilea names Adesh Kaul as new member of its Management
www.globenewswire.com
Basel, Switzerland, March 01, Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Adesh Kaul will join Basilea's Management Committee as Chief Corporate Development Officer effective March 01, He will continue to be responsible for strategic planning, business development & licensing, investor relations and public relations. Mr. Kaul has served as Basilea's Head of Corporate Development and as a member of Basilea's Extended ...
未指定: stuttgart
Basilea Pharmaceutica : announces change in the Management ...m.marketscreener.com › BASILEA-PHARMACEUTICA-AG › news
m.marketscreener.com
Basel, February 7, Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the Board of Directors has appointed Adesh Kaul, currently Chief ...
Basilea Pharmaceutica Ltd.. ( ). "Press Release: Basilea ...www.life-sciences-europe.com › news › basilea-extends-cresemba-license-b...
www.life-sciences-europe.com
"Press Release: Basilea Names Adesh Kaul as New Member of its Management Committee". Basel.... [3] Basilea Pharmaceutica Ltd.. ( ). "Press Release: ...
sortiert nach Relevanz / Datum